Alzheimer's Disease Trial, Not Yet Recruiting NCT07200739 Sponsor: Zealand University Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07200739
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

Model A – Patient participants:

  • People aged over 50 years
  • People who are fluent in Danish
  • People who have completed at least 7 years of schooling
  • People who have been diagnosed with either mild cognitive impairment (MCI) or Alzheimer's disease (AD) at the SUH memory clinic within the 6 months before joining the trial

Model A – Cognitively healthy controls (people without a memory diagnosis):

  • People aged over 50 years
  • People who are fluent in Danish
  • People who have completed at least 7 years of schooling

Model B:

  • People aged over 50 years
  • People who are fluent in Danish
  • People who have completed at least 7 years of schooling

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

Model A – Patients:

  • People whose vision or hearing is significantly impaired to the point where it would prevent participation in the AI analysis
  • People whose score on a standard memory and thinking test (called the MMSE) is below 16
  • People who have another condition that is expected to affect memory or thinking, such as depression
  • People who are not able to give their own consent to participate
  • People who drink more than 21 standard alcoholic drinks per week
  • People who had a speech or language problem before their current condition began

Model A – Cognitively healthy controls:

  • People whose vision or hearing is significantly impaired to the point where it would prevent participation in the AI analysis
  • People whose scores on standard memory and thinking tests (MMSE below 26 and ACE below 90) fall below the set thresholds
  • People with clinical, laboratory, or brain scan findings that could affect thinking and memory
  • People with a known condition expected to affect thinking and memory
  • People who had a speech or language problem before their current condition began
  • People who drink more than 21 standard alcoholic drinks per week

Model B:

  • People whose vision or hearing is significantly impaired to the point where it would prevent participation in the AI analysis
  • People whose score on a standard memory and thinking test (called the MMSE) is below 16
  • People who are not able to give their own consent to participate
  • People who have a concurrent diagnosis of psychosis or a severe psychiatric condition other than depression
  • People who had a speech or language problem before their current condition began

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Peter Høgh, MD, PhD, Assoc Prof, Zealand University Hospital

Phone: +4530294621

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Zealand University Hospital
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 May 2028

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Model A: Primary measure is the AUC-ROC of the model in distinguishing between MCI and AD as well as between MCI and cognitively healthy control participants.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov